Contra Costa County Header
File #: 24-3693    Version: 1 Name:
Type: Consent Item Status: Passed
File created: 10/21/2024 In control: BOARD OF SUPERVISORS
On agenda: 11/5/2024 Final action: 11/5/2024
Title: APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a blanket purchase order with Tri-Pharma, Inc. in an amount not to exceed $1,500,000 for the purchase of intravenous solutions, RhoGAM and other supplies as needed for Contra Costa Health for the period from October 1, 2024 through September 30, 2026. (100% Hospital Enterprise Fund I)
To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Purchase Order with Tri-Pharma, Inc.
?Recommendation of the County Administrator ? Recommendation of Board Committee


RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a blanket purchase order with Tri-Pharma, Inc. in an amount not to exceed $1,500,000 for the purchase of intravenous (IV) solutions, RhoGAM and other supplies as needed for Contra Costa Health (CCH) for the period of October 1, 2024, through September 30, 2026.

FISCAL IMPACT:
Approval of this action will result in expenditures of up to $1,500,000 and will be funded 100% by Hospital Enterprise Fund I revenues.

BACKGROUND:
Tri-Pharma Inc. is a pharmaceutical wholesaler that focuses on the distribution of FDA-approved prescription and over-the-counter pharmaceuticals to a wide range of clients, including hospitals, government facilities, and specialty healthcare providers. The company emphasizes strong relationships with its trading partners to ensure high-quality and competitively priced products. Their operations are supported by state-of-the-art systems for inventory management and delivery, which allow them to ship essential medications across the U.S. within one to two days.

Tri-Pharma Inc. has been selected to address procurement challenges for essential medical and pharmaceutical supplies that have become unavailable due to recent hurricanes in the southeastern U.S. The hurricanes severely impacted several suppliers by affecting manufacturing warehouses, leading to widespread shortages, in IV solutions particularly. As a result, Tri-Pharma's ability to source and deliver high-quality, FDA-approved products positions it as a critical partner in ensuring uninterrupted supply during this period of recovery and disruption.

CONSEQUENCE OF NEGATIVE ACTION:
If this purchase order is not approved, CCH will be unable to provide the necessary m...

Click here for full text